New publication in CMI: A pharmacometric approach to define target site-specific breakpoints for bacterial killing and resistance suppression integrating microdialysis, time-kill curves and heteroresistance data: A case study with moxifloxacin
25 February 2020, by Broeker
Khalid Iqbal published his first article of his PhD work with us in Clinical Microbiology and Infection titled “A pharmacometric approach to define target site-specific breakpoints for bacterial killing and resistance suppression integrating microdialysis, time-kill curves and heteroresistance data: A case study with moxifloxacin”. Congratulations!